Eton Pharmaceuticals

We are excited to announce that Eton Pharmaceuticals has successfully completed the acquisition of Increlex® (mecasermin injection). This transformative addition to our pediatric endocrinology portfolio reinforces our commitment to advancing care for rare diseases. Read the full press release here: https://lnkd.in/gV9dYYn8. We are proud to continue providing this essential treatment and look forward to collaborating with healthcare professionals and the patient and caregiver community. This content is intended for informational purposes only. Full U.S. Prescribing Information for Increlex® is available at: https://lnkd.in/gWgKKApQ. #PatientFirst #PediatricEndocrinology #RareDiseases #Increlex #EtonPharmaceuticals #PressRelease

We proudly announce the Final Readout of PKU GOLIKE® Clinical Trial, a significant milestone in our mission to deliver innovative solutions for PKU patients.   Clinical trial demonstrates clinical and statistical improvement in metabolic control during prolonged fasting in PKU patients.   This achievement reflects our ongoing commitment to addressing unmet needs and improving the lives of patients and families worldwide. Read the full press release here: https://lnkd.in/gV9dYYn8. [News intended for Investors and Media]   At Eton, we remain dedicated to advancing healthcare and delivering meaningful solutions for those who need them most. #PatientFirst #PKU #RareDisease #PKUGOLIKE #PressRelease #EtonPharmaceuticals #InnovationInHealthcare

We’re #hiring! Eton Pharmaceuticals is seeking a Rare Disease Specialist to cover our Midwest region. Apply today or share with your network!

We’re #hiring! Eton Pharmaceuticals is seeking a Rare Disease Specialist to cover our Western region. Apply today or share this post with your network!

We're hiring a Senior Accounting Manager. Apply today or share this post with your network!

Today, on National PKU Awareness Day, we stand with the PKU community to raise awareness about phenylketonuria (PKU)—a rare genetic condition that requires lifelong management. At Eton Pharmaceuticals, we are proud to support individuals and families navigating this journey by providing innovative metabolic products designed to enhance quality of life for those with PKU. Together, let’s continue to educate, advocate, and innovate for a brighter future for the PKU community. #PKUAwareness #NationalPKUAwarenessDay #EtonPharmaceuticals #RareDisease #GeneticDisorders

This Thanksgiving, we want to express our deepest gratitude to all who make our mission possible: - Our patients and families, who inspire us every day with their resilience and determination. - Our dedicated team, whose commitment to innovation and excellence drives everything we do. - Our partners and healthcare providers, who share our vision of improving lives through meaningful solutions. At Eton Pharmaceuticals, we’re proud to serve the rare disease community and remain thankful for the opportunity to make a difference. Wishing you and your loved ones a joyful Thanksgiving filled with warmth, gratitude, and good health. #Thanksgiving #Gratitude #RareDisease #EtonPharmaceuticals

November is National Caregivers Month At Eton Pharmaceuticals, we salute the caregivers who work tirelessly to support loved ones in managing rare diseases. Your strength and dedication inspire us to provide better treatments and provide meaningful resources. Together, we can make a difference. #CaregiversMonth #Gratitude #RareDiseases #EtonPharmaceuticals

We're hiring a Regulatory Affairs Manager. Apply today or share this post with your network!

Eton is excited to announce the acquisition of another pediatric endocrinology product. https://bit.ly/4gUnIcw